Figure 1

Figure 1. From: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.

Incidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.

Juliana Levy, et al. Diabetol Metab Syndr. 2010;2:16-16.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk